ICOA conferences in april 2023: thursday 13/04 at 11:00 seminar room of ICOA Dr. Cyril Ollivier (Paris Sorbonne University) «Radical Processes and Organometallic Catalysis under Visible Light Activation» Contact: Marie-Aude HIEBEL ICOA – UMR 7311 / Université d’Orléans rue de Chartres B.P. 6759 – F-45067 Orléans Cedex 2, France mailto: marie-aude.hiebel@univ-orleans.fr tel: + 33 (0)2 38 49 45...
Lire plus »Research Topic: Recent Advances in Nanoradiopharmaceuticals for Molecular Imaging and Radiotherapy This Research Topic welcomes submissions dealing with recent progresses in the field of nanomedicine and radiopharmaceuticals, with new approaches to the design and formulation of innovative radiolabeled nanoconstructs and their applications. Original research, as well as review articles, on the use of nanomaterials for receptor-specific tumor targeting, radionuclide...
Lire plus »Registration is now open! Over four days, 20 participants will deepen their knowledge in some of the main fields of nuclear medicine research, with a focus on alpha-emitting radionuclides (astatine-211 especially). They have the opportunity to meet some of the best international experts in radiopharmaceuticals production, artificial intelligence for medical image analysis, and theranostic approaches. Lectures, practical works and visits take place in four major research...
Lire plus »The LabEx IRON would like to congratulate François Guérard, researcher at CRCI2NA Nantes (partner of the LabEx IRON), winner of a Consolidator Grant from the European Research Council (ERC) for his project SAt-Radio: Stable 211At-labeled radiopharmaceuticals for targeted α therapy. From his thesis work (defended in 2010 in Nantes), François Guérard became interested in the chemistry of astatine, an extremely rare element which disintegrates in a few hours and which could...
Lire plus »For the 2nd time in a row, the ILIAD project is labeled SIRIC for 5 years! Supported by Nantes University Hospital, Angers University Hospital & Western Cancer Institute (ICO), the renewal of SIRIC ILIAD by the National Cancer Institute (INCa) is proof of the excellence of the Nantes-Angers research site , integrating medical, scientific & social research in breast cancer and multiple myeloma. For the next 5 years, SIRIC ILIAD’s mission will be to conduct...
Lire plus »Dear Colleagues, As the guest editor of the Special Issue on “Brain Tumors and Their Microenvironment: Focus on Hypoxia, Oxidative Stress and Inflammation” of the International Journal of Molecular Sciences (IJMS, IF 6.208, JCR Q1), I sincerely invite you to contribute a full research article or comprehensive review for peer-review and possible publication. We believe that your work on this extensive and interconnected field could make an excellent contribution to the...
Lire plus »